 In Q4/2017, the Company and its subsidiary recorded total sales of Baht 1,531 million, an increase of 2% YoY, following growth from domestic CMG launching new products as well as continue growth from

increase profit of 510%. Excluding, the reversal of impairment loss of assets of Baht 486.70 million, the group incurred a net loss for the year ended 31 December 2019 of Baht 81.46 million. The Company

, comparing at the same period in 2016 representing 79.98% increase. This is mainly due to : 1. Income from medical treatments in the consolidated financial went up6.80% due to income from Chiang Mai Ram

298.18 million , comparing at the same period in 2016 representing 31.43% increase. This is mainly due to : 1. Income from medical treatments in the consolidated financial went up 10.10% due to income from

increase by 0.39 million baht due to cost reduction of advertising and support department increase by 0.69 million baht. Other expenses decreased 0.30 million baht. The cost of administration for the three

Mai Ram Medical Business Plc., (CMR) amount Baht 999.56 million. comparing at the same period in 2018 representing 3.38% increase . Income from medical treatments in the separate financial went down

• Gross profit from sales of real estate was THB 215.8mn, decreased 24.6% YoY, and GPM was 27.9% • Total assets as of 30 June 2018 stood at THB 12,753.0mn, an increase of THB 2,295.0mn • Debt to Equity

with fair treatment and transparency, and increase flexibility for management of member contribution. Most respondents agreed with the proposed amendments and suggested further details for the

funds that will help increase liquidity and allow debt issuers affected by the COVID-19 pandemic to continue their business operation (bridge financing). This in turn will increase liquidity and

retirement savings more than the minimum estimate of 3 million baht**.” The SEC has therefore proposed guidelines for amending the Provident Fund Act B.E. 2530 (1987) to increase PVD efficiency in